News
All NewsBlogs
Media
All VideosCase-Based Roundtable SeriesEichenbaum AcornsExpert InterviewsEyeviewsInsightsMedical World NewsPodcastsRapid ReadoutsThe Retina TL;DRViewpoints
Conference
Conference CoverageConference Listing
Publications
Modern Retina Digital EditionSupplements And Featured Publications
More
Resources
Between the LinesCME/CEEYLEA 8mg for nAMD and DME TreatmentSponsored Resources
Partners

Subscribe

  • News
  • Media
  • Conference
  • Publications
  • Resources
  • Partners
  • Subscribe
  • AMD
    • Wet AMD
  • Biosimilar
  • Diabetic Macular Edema
    • Diabetic Eye Awareness
  • Diabetic Retinopathy
  • Geographic Atrophy
  • Imaging
  • Inherited Retinal Diseases
  • Ophthalmology
    • Europe
  • RVO
  • Retina Technology
  • Retinal Surgery
  • Uveitis
Spotlight -
Geographic Atrophy
Advertisement

Updates in DME, diabetic retinopathy

EP. 1: Overview of diabetic eye disease

December 1st 2020

EP. 2: Imaging for diabetic retinopathy

December 1st 2020
Evaluating the use of OCT-A for patients with diabetes in clinical practice and whether it should become a standard of care.

EP. 3: Use of OCT-A for patients with diabetes

December 1st 2020
A discussion on educating a patient with diabetes on disease management, including routine hemoglobin A1C screenings to optimize health, and sending a referral to a retina specialist.

EP. 4: Optimizing diabetes health management

December 1st 2020
Experts discuss successful communication among optometrists, retina specialists, and primary care providers when treating a patient with diabetes.

EP. 5: Diabetes management: Communication between ODs and MDs

December 1st 2020

EP. 6: ADA guidelines for DR/DME management

December 1st 2020

EP. 7: Treatment options for DR/DME

December 1st 2020

EP. 8: Challenges to diabetes management

December 1st 2020

EP. 9: Impact of COVID-19 on management of DR/DME

By
December 1st 2020

EP. 10: Emerging agents for the treatment of DR/DME

December 1st 2020
Advertisement
Advertisement

Trending on Modern Retina

1

Pipeline update: Catch up on recent updates in the retina pipeline

2

AAO 2025: The safety and efficacy of oral gildeuretinol in participants with intermediate-stage Stargardt disease

3

Evolving strategies in retinal care: Navigating today’s treatment landscape

4

ONL Therapeutics randomizes first patient in phase 2 GALAXY trial evaluating xelafaslatide

  • About
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us